Cleared Special

AltiVate Reverse? Glenoid

K252141 · Encore Medical, L.P. · Orthopedic

Aug 2025

Decision

28d

Days

Class 2

Risk

About This 510(k) Submission

K252141 is an FDA 510(k) clearance for the AltiVate Reverse? Glenoid, a Shoulder Prosthesis, Reverse Configuration (Class II — Special Controls, product code PHX), submitted by Encore Medical, L.P. (Austin, US). The FDA issued a Cleared decision on August 5, 2025, 28 days after receiving the submission on July 8, 2025. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3660.

Submission Details

510(k) Number	K252141 FDA.gov
FDA Decision	Cleared SESE
Date Received	July 08, 2025
Decision Date	August 05, 2025
Days to Decision	28 days
Submission Type	Special
Review Panel	Orthopedic (OR)
Summary	Summary PDF

Device Classification

Product Code	PHX — Shoulder Prosthesis, Reverse Configuration
Device Class	Class II — Special Controls
CFR Regulation	21 CFR 888.3660
Definition	Intended To Be Used To Relieve Pain And To Replace The Glenoid And Humeral Side Of The Shoulder Joint In Order To Restore Mobility In A Grossly Rotator Cuff Deficient Joint With Severe Arthropathy Or A Previous Joint Replacement With A Grossly Rotator Cuff Deficient Joint.